Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan

Published:2024-03-07 Issue:4 Volume:40 Page:723-731
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Yoshida Yuichi¹^ORCID,Tozawa Keiichi²^ORCID,Koto Ryo²^ORCID,Iwao Chikako²^ORCID,Kim YongJin³^ORCID,Ban Lu⁴^ORCID,Barut Volkan⁵^ORCID

Affiliation:

1. Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan

2. AstraZeneca K.K, Osaka, Japan

3. Evidera, Saint-Laurent, Canada

4. Evidera, PPD, Beijing, China

5. AstraZeneca, Cambridge, UK

Funder

AstraZeneca

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2322698

Reference16 articles.

1. Neurofibromatosis type 1

2. Neurofibromatosis type 1: a multidisciplinary approach to care

3. Yoshida Y. Neurofibromatosis. In: Kelly AP, Taylor SC, editors. Taylor and Kelly’s dermatology for skin of color. 2nd ed. New York (NY): McGrawHill Press; 2016.

4. Malignancy in Neurofibromatosis Type 1

5. Niimura M. Neurofibromatosis in Japan. In: Ishibashi Y, Hori Y. editors. Tuberous sclerosis and neurofibromatosis:epidemiology, pathophysiology, biology and management. Amsterdam: Excerpta Medica. 1990. p. 22–31.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP